Rudolph Hulspas
Dana-Farber Cancer Institute
Seminars
Wednesday 16th September 2026
Optimizing Starting Materials to Enable Future Scalable Cell Therapy Production
11:15 am
- Providing strategies to effectively isolate key starting materials to enhance product yield
- Assessing cell phenotype and fitness to understand how starting material quality impacts manufacturing success
- Applying engineering and process innovations to improve low quality autologous starting material and enable reliable production for clinical supply
